EPIDERMAL GROWTH-FACTOR IS A POTENT INHIBITOR OF RENIN SECRETION

被引:7
作者
ANTONIPILLAI, I
机构
[1] Unit I, Division of Endocrinology, USC Medical Center, Los Angeles, CA 90033
关键词
EPIDERMAL GROWTH FACTOR; CYCLOOXYGENASE; RENIN; ANGIOTENSIN-II; KIDNEY;
D O I
10.1161/01.HYP.21.5.654
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Epidermal growth factor (EGF) is not only a cell mitogen but a potent vasoconstrictor that shares many properties with angiotensin II. Because EGF is localized in the kidney, we have studied the direct effects of EGF on renin secretion using both static incubations and perifusions of rat renal cortical slices. EGF at 5 x 10(-9) M significantly inhibited renin secretion in static incubations (control, 100+/-3%; EGF, 72+/-3%; p<0.001). When added to perifusions, EGF acted rapidly, reducing renin secretion at the earliest time period (10 minutes). Similarly, transforming growth factor-alpha, which can bind to the EGF receptor, also inhibited renin secretion (control, 92+/-8%; transforming growth factor-alpha [2 x 10(-9) M], 63+/-4%; p<0.02). Because both prostaglandins and lipoxygenase products of arachidonic acid have been shown to play a role in some EGF-mediated actions, we examined these possible mechanisms of EGF action. Meclofenamate, a cyclooxygenase blocker, and BW755c and baicalein, both lipoxygenase blockers, were studied. None of these agents altered EGF-mediated renin inhibition. EGF action has also been coupled to the stimulation of tyrosine kinase activity; therefore, we examined the effects of the tyrosine kinase inhibitors genistein and quercetin. Both genistein (10(-5) M) and quercetin (10(-5) M) abolished the inhibition of renin by EGF (control, 100+/-3%; EGF, 82+/-4%; EGF plus genistein, 110+/-7%; p<0.01; EGF, 75+/-4%; EGF plus quercetin, 92+/-4%; p<0.01). These results suggest that EGF is a potent inhibitor of renin release and that eicosanoids do not play a role in EGF action. However, blockade of tyrosine kinase activity prevents EGF inhibition of renin secretion. These studies support a potential paracrine role of EGF in renin secretion.
引用
收藏
页码:654 / 659
页数:6
相关论文
共 38 条
[1]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[2]   ANGIOTENSIN FEEDBACK INHIBITION ON RENIN IS EXPRESSED VIA THE LIPOXYGENASE PATHWAY [J].
ANTONIPILLAI, I ;
NADLER, J ;
HORTON, R .
ENDOCRINOLOGY, 1988, 122 (04) :1277-1281
[3]   ROLE OF EXTRA-CELLULAR AND INTRACELLULAR CALCIUM AND CALMODULIN IN RENIN RELEASE FROM RAT-KIDNEY [J].
ANTONIPILLAI, I ;
HORTON, R .
ENDOCRINOLOGY, 1985, 117 (02) :601-606
[4]   THE INHIBITORY ROLE OF 12-LIPOXYGENASE AND 15-LIPOXYGENASE PRODUCTS ON RENIN RELEASE [J].
ANTONIPILLAI, I ;
NADLER, JL ;
ROBIN, EC ;
HORTON, R .
HYPERTENSION, 1987, 10 (01) :61-66
[5]   A 12-LIPOXYGENASE PRODUCT OF ARRACHIDONATE METABOLISM IS INVOLVED IN ANGIOTENSIN ACTION ON RENIN RELEASE [J].
ANTONIPILLAI, I ;
HORTON, R ;
NATARAJAN, R ;
NADLER, J .
ENDOCRINOLOGY, 1989, 125 (04) :2028-2034
[6]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 MAY REGULATE RENIN SECRETION [J].
ANTONIPILLAI, I ;
WANG, Y ;
HORTON, R .
ENDOCRINOLOGY, 1990, 126 (01) :273-278
[7]   ANATOMY OF THE JUXTAGLOMERULAR APPARATUS [J].
BARAJAS, L .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 237 (05) :F333-F343
[8]   EPIDERMAL GROWTH-FACTOR, A VASCULAR SMOOTH-MUSCLE MITOGEN, INDUCES RAT AORTIC CONTRACTION [J].
BERK, BC ;
BROCK, TA ;
WEBB, RC ;
TAUBMAN, MB ;
ATKINSON, WJ ;
GIMBRONE, MA ;
ALEXANDER, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (03) :1083-1086
[9]   VASOACTIVE EFFECTS OF GROWTH-FACTORS [J].
BERK, BC ;
ALEXANDER, RW .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (02) :219-225
[10]   EPIDERMAL GROWTH-FACTOR INHIBITS THE HYDROOSMOTIC EFFECT OF VASOPRESSIN IN THE ISOLATED PERFUSED RABBIT CORTICAL COLLECTING TUBULE [J].
BREYER, MD ;
JACOBSON, HR ;
BREYER, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (04) :1313-1320